Hexartan AM H Tablet is a combination antihypertensive medication containing Telmisartan 40 mg, Amlodipine 5 mg, and Hydrochlorothiazide 12.5 mg. This formulation is designed to effectively manage hypertension by targeting different physiological pathways. Telmisartan, an angiotensin II receptor blocker (ARB), inhibits the vasoconstrictive effects of angiotensin II, thereby reducing peripheral vascular resistance and lowering blood pressure. Amlodipine, a calcium channel blocker, promotes vasodilation by inhibiting calcium influx into vascular smooth muscle cells, which further decreases systemic vascular resistance. Hydrochlorothiazide, a thiazide diuretic, facilitates the excretion of sodium and water through the kidneys, reducing blood volume and contributing to blood pressure reduction. The synergistic action of these three agents provides comprehensive blood pressure control, particularly in patients who require multiple mechanisms of action to achieve target levels. Hexartan AM H is indicated for the treatment of essential hypertension, especially in patients inadequately controlled on monotherapy or dual therapy. It should be used under medical supervision, with monitoring of renal function, electrolytes, and blood pressure. Caution is advised in patients with renal or hepatic impairment, electrolyte imbalances, or hypersensitivity to any component. Regular follow-up is essential to optimize therapy and minimize adverse effects.